Antiepileptic drugs in pregnancy and hemorrhagic disease of the newborn: An update

Aleksey Kazmin, Renee C. Wong, Mathew Sermer, Gideon Koren

Research output: Contribution to journalShort surveypeer-review

9 Scopus citations

Abstract

QUESTION: What is the current evidence regarding the association between hemorrhagic disease of the newborn and maternal use of hepatic enzyme-inducing antiepileptic drugs (eg, carbamazepine, phenobarbitone, topiramate)? ANSWER: Women with epilepsy who take enzyme-inducing antiepileptic drugs should be advised that there is no adequate evidence to support or refute taking vitamin K in late pregnancy to prevent bleeding complications in a newborn.

Original languageEnglish
Pages (from-to)1291-1292
Number of pages2
JournalCanadian Family Physician
Volume56
Issue number12
StatePublished - Dec 2010
Externally publishedYes

Fingerprint

Dive into the research topics of 'Antiepileptic drugs in pregnancy and hemorrhagic disease of the newborn: An update'. Together they form a unique fingerprint.

Cite this